129 related articles for article (PubMed ID: 34486997)
1. The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer.
Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2021; 43(1):209-223. PubMed ID: 34486997
[TBL] [Abstract][Full Text] [Related]
2. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
[TBL] [Abstract][Full Text] [Related]
3. The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.
AbdelMageed M; Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752131
[TBL] [Abstract][Full Text] [Related]
4. Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2020 Jun; 42(6):1010428320924524. PubMed ID: 32515296
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.
AbdelMageed M; Ismail HTH; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008827
[TBL] [Abstract][Full Text] [Related]
6. Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer.
Ali H; AbdelMageed M; Olsson L; Israelsson A; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2019 Jun; 41(6):1010428319858885. PubMed ID: 31250711
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of the chemokine CXCL17 in colon cancer cells.
Ohlsson L; Hammarström ML; Lindmark G; Hammarström S; Sitohy B
Br J Cancer; 2016 Mar; 114(6):697-703. PubMed ID: 26889977
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of EMR1 (ADGRE1) by Tumor-Associated Macrophages Promotes Colon Cancer Progression by Activating the JAK2/STAT1,3 Signaling Pathway in Tumor Cells.
Akter R; Park R; Lee SK; Han EJ; Park KS; Park J; Cho MY
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673975
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic values of C‑X‑C motif chemokine ligand 3 in patients with colon cancer.
Ruan GT; Gong YZ; Liao XW; Wang S; Huang W; Wang XK; Zhu GZ; Liao C; Gao F
Oncol Rep; 2019 Nov; 42(5):1996-2008. PubMed ID: 31545503
[TBL] [Abstract][Full Text] [Related]
10. GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1.
Wen Y; Giardina SF; Hamming D; Greenman J; Zachariah E; Bacolod MD; Liu H; Shia J; Amenta PS; Barany F; Paty P; Gerald W; Notterman D
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5951-9. PubMed ID: 17062666
[TBL] [Abstract][Full Text] [Related]
11. Cartilage Oligomeric Matrix Protein, COMP may be a Better Prognostic Marker Than CEACAM5 and Correlates With Colon Cancer Molecular Subtypes, Tumor Aggressiveness and Overall Survival.
Wusterbarth E; Chen Y; Jecius H; Krall E; Runyan RB; Pandey R; Nfonsam V
J Surg Res; 2022 Feb; 270():169-177. PubMed ID: 34687957
[TBL] [Abstract][Full Text] [Related]
12. EMR1/ADGRE1 Expression in Cancer Cells Upregulated by Tumor-Associated Macrophages Is Related to Poor Prognosis in Colorectal Cancer.
Akter R; Kim K; Kwon HY; Kim Y; Eom YW; Cho HM; Cho MY
Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551877
[TBL] [Abstract][Full Text] [Related]
13. LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer.
Nagata H; Ishihara S; Abe H; Ushiku T; Kishikawa J; Tanaka T; Hata K; Kawai K; Fukayama M; Nozawa H
Br J Cancer; 2019 May; 120(10):996-1002. PubMed ID: 31000786
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of
Ismail HTH; AbdelMageed M; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562947
[TBL] [Abstract][Full Text] [Related]
15. Detection of lymph node metastasis in colon cancer by ectopically expressed fibroblast markers FOXQ1 and THBS2.
Ali H; AbdelMageed M; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Front Oncol; 2023; 13():1297324. PubMed ID: 38156105
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.
Blumenthal RD; Leon E; Hansen HJ; Goldenberg DM
BMC Cancer; 2007 Jan; 7():2. PubMed ID: 17201906
[TBL] [Abstract][Full Text] [Related]
17. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.
Dong P; Ma L; Liu L; Zhao G; Zhang S; Dong L; Xue R; Chen S
Int J Mol Sci; 2016 Mar; 17(3):320. PubMed ID: 26938527
[TBL] [Abstract][Full Text] [Related]
18. [
Liu L; Yang Y; Zhou JY; Wu YF; Zhao L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Feb; 56(2):175-181. PubMed ID: 33557502
[No Abstract] [Full Text] [Related]
19. KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients.
Wang XM; Zhang Z; Pan LH; Cao XC; Xiao C
Breast Cancer Res Treat; 2019 Apr; 174(2):375-385. PubMed ID: 30535933
[TBL] [Abstract][Full Text] [Related]
20. A Distinct Microglial Cell Population Expressing Both CD86 and CD206 Constitutes a Dominant Type and Executes Phagocytosis in Two Mouse Models of Retinal Degeneration.
Zhang Y; Park YS; Kim IB
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
